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Abstract
E2F and DP family proteins are evolutionally conserved transcription factors 
among higher eukaryotes. E2F and DP proteins typically form a heterodimeric 
complex, which controls cell proliferation by regulating expression of growth-
related genes. In addition, E2F family proteins have roles in various cellular events 
that require the expression of context-specific genes. E2F proteins use distinct 
mechanisms to regulate context-specific genes in different circumstances. The 
primary goal of this chapter is to compare three distinct mechanisms of mam-
malian E2F-mediated transcriptional regulation that control cell proliferation, 
endoreplication and apoptosis. Briefly, E2F7 and E2F8 control endoreplication by 
suppressing the expression of their target genes. They do not require DP or pRb. In 
control of apoptosis, E2F1 regulates the expression of the tumor suppressor gene 
Arf by binding to a non-canonical E2F binding site, within the Arf promoter, in a 
DP-independent manner. Furthermore, we examine the functions of E2F and DP in 
Drosophila melanogaster (fruit fly) to identify those mechanisms of E2F-mediated 
transcriptional regulation that have been evolutionarily conserved. The detailed 
mechanisms of how E2F protein regulates the expression of context-specific target 
genes will be instrumental in understanding how a single family of transcription 
factor regulates diverse pleiotropic cellular processes in an organism.
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1. Introduction
The temporal control of gene expression is essential to the execution of cellular 
events such as proliferation, growth, self-renewal, differentiation and death. For 
example, a proliferating cell performs the sequential processes of the cell cycle by 
the orderly expression of genes involved in DNA replication, DNA repair, mitosis 
and cytokinesis [1, 2]. During the cell cycle, E2 promoter binding factor (E2F) and 
DRTF1-polypeptide (DP) form a heterodimeric complex E2F/DP, which functions 
with retinoblastoma protein (pRb) to regulate the timing of expression of growth-
related genes at the level of transcription [1–5]. In quiescent cells, the E2F/DP 
complexes interact with pRb family proteins to prevent cell cycle re-entry by actively 
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repressing the expression of growth-related genes (Figure 1A and B). Mitogenic 
signals promote the assembly and activation of the Cyclin D/cyclin-dependent 
kinase (cdk) 4 complex in the cell nucleus. Phosphorylation of pRb family proteins 
by the Cyclin D-cdk4 complex results in their dissociation from the E2F/DP complex 
(Figure 1A), and consequently growth-related genes are de-repressed. The free E2F/
DP complexes also promote transcription of their target genes (Figure 1A and B). 
Primary E2F target genes in the cell cycle encode DNA-replication factors. In addi-
tion, the E2F/DP complex induces the expression of cyclins (E, A, and B) and genes 
involved in DNA repair, mitosis and cytokinesis. Thus, the pRb/E2F/DP pathway 
controls not only the G1/S transition, but also influences other processes of the cell 
cycle. Once the level of mitogen signals is reduced, cdk activity is down-regulated, 
under-phosphorylated pRb family proteins accumulate, E2F activity is repressed, 
and cells exit from the cell cycle.
Genome wide gene expression profiles and analysis of the function of individual 
E2F family proteins have revealed that E2F family members have roles in various 
cellular processes including endoreplication [6], cell death [7], autophagy [8] and 
differentiation [9]. Since it is unlikely that E2F simultaneously induces genes involved 
in these distinct, often mutually exclusive cellular processes, cells must have multiple 
mechanisms, by which specific E2F target genes are expressed to function in line with 
intracellular circumstances. Indeed, the mechanism of E2F1 regulation of tumor sup-
pressor genes, Alternative reading frame of cdkn2a (Arf ), p27 and p73 is distinct from 
that of growth-related genes [10–12]. Surprisingly, the requirement for DP is different 
between E2F1 regulation of Arf and growth-related genes such as cell division cycle 6 
(cdc6), implying that DP protein is not involved in all E2F-mediated transcriptional 
regulation [13]. In this chapter, we describe mechanisms of E2F-mediated transcrip-
tional regulation in three different cellular functions, cell proliferation, endoreplica-
tion and apoptosis, and discuss the requirement for DP in these processes. In addition, 
we compare and contrast these mechanisms in mammals and flies, to identify those 
that have been conserved or emerged during the process of evolution.
Figure 1. 
The E2F/DP complex controls cell cycle progression with pRB. (A) Schematic view of the pRb/E2F/DP 
pathway. Solid line indicates the function of pRb/E2F/DP complex to repress the expression of growth-related 
E2F-target genes in quiescence. Dashed arrows indicate the signal cascade following activation by mitogenic 
signals. pRb-P indicates phosphorylated pRb. (B) Regulation of growth-related E2F target genes by the pRB/
E2F/DP complex during the cell cycle. The pRb/E2F/DP complex actively represses the transcription of growth-
related E2F target genes in quiescence, while free activator E2F/DP complex promotes transcription of the 
target genes when pRb family proteins are phosphorylated by G1-cyclin/cdk.
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2. Structures of mammalian and fly E2F and DP family members
The human and mouse genomes contain eight E2F family genes and three DP 
family genes (Figure 2) [3]. E2F family proteins can be distinguished as “activa-
tor” or “repressor” by their functions in transcription, or “typical” or “atypical” 
based on their structure. E2F1–5 genes encode proteins composed of a winged-
helix DNA-binding domain (DBD), Leucine zipper (LZ) domain, Marked-box 
(MB) domain and transactivation domain (TAD) that includes pRb-binding 
motif (Figure 2). E2F6 protein lacks the TAD and pRb-binding motif (Figure 2). 
E2F1–3a are categorized as activator E2Fs because they are essential to activate 
transcription of target genes in cell culture [3]. E2F3b-5 are designated repres-
sor E2Fs since their main function is to suppress the expression of target genes 
by interacting with pRb family proteins in resting states [14–16]. E2F6 is also a 
repressor E2F, but functions without interacting pRb family proteins [17–19]. 
E2F1–6 proteins interact with one of the DP proteins through LZ and MB 
domains (dimerization domain: DD). All DP family members possess a DBD and 
DD [3]. In addition, the C-terminus of DP1 can interact with TFIIH, suggesting 
that DP1 directly contributes to activation of target gene transcription [20]. DP1 
and DP2 support the transcriptional activation of E2F target genes while DP3 
functions to inhibit E2F-dependent transcription [21, 22]. The E2F/DP complex 
typically recognizes specific DNA sequences TTTC/G
G/CCG
C/G (hereafter referred 
to as “canonical E2F binding site” in this chapter) [23]. E2F1 is also able to 
Figure 2. 
E2F and DP family members in human, mouse and fly. E2F families can be divided into two groups by 
functional or structural properties. Activator E2Fs are required to induce expression of growth-related E2F 
target genes at G1/S phase transition. E2F3a-5 are expressed in quiescence (G0) and G1 phase to repress target 
gene transcription by pRb-dependent mechanisms. E2F6–8 have the ability to repress target gene transcription 
by pRb-independent mechanisms. Typical E2Fs possess DBD, LZ, MB and TAD, while atypical E2Fs possess 
two DBD without a TAD. DP family proteins share DBD and LZ. TAD is found in mammalian DP1.
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bind to a non-canonical E2F binding site called E2F-responsive element of Arf 
(EREA), comprised of the sequence CGCGCGCGCGCCTCC [10].
After completion of the human and mouse genome sequencing projects, 
searches for homologous sequences to the E2F-DBD identified atypical E2F family 
members, E2F7 and E2F8 that are structurally distinct from E2F1 to 6 (Figure 2) 
[24–29]. E2F7 and 8 contain two DBDs but lack a transactivation domain. These 
atypical E2Fs recognize canonical E2F binding sites in a DP-independent manner 
and function to repress transcription of E2F target genes by a pRb-independent 
mechanism.
The fly genome contains two e2f genes and a single dp gene [3, 4, 30]. de2f1 
encodes two isoforms, which function as transcriptional activators, while dE2f2 acts 
as a repressor in transcription (Figure 2) [31, 32]. Because all other higher eukary-
otes also possess functional homolog of activator E2F, repressor E2F and DP, the 
mechanism of transcriptional control by the E2F/DP complex has been evolution-
ally conserved [33]. Atypical E2Fs are shared in several model organisms including 
mammals, worm and plant, but not in fly (Figure 2) [33]. DP-independent tran-
scriptional regulation by atypical E2Fs seems to have been emerged and been lost 
during the process of evolution.
3. The role of the E2F/DP complex in cell proliferation
3.1 DP is essential in transcriptional regulation of growth-related E2F target 
genes in cultured cells
The concept of the pRb/E2F/DP pathway is based primarily on evidence 
obtained using rodent fibroblasts in culture [1–5]. The advantage of this system 
is the ease of manipulating the proliferative capacity of cells without losing cell 
viability by the absence or presence of fetal bovine serum in the culture medium 
[34, 35]. Fibroblasts continuously proliferate in culture medium that contains 
abundant serum. Withdrawing serum from the media causes cells to exit from the 
cell cycle, while re-introduction of serum leads to re-entry into the cell cycle. Thus, 
this system enables control of endogenous E2F activity by manipulating the amount 
of serum in culture media. In addition, using expression vectors and recombinant 
adenovirus containing various E2F genes, we can examine the specific activity of 
individual E2F proteins in quiescent fibroblast without other confounding prolif-
erating signals [2]. The functional analysis of individual E2F proteins in quiescent 
fibroblasts revealed that activator E2Fs are sufficient to promote the G1/S transition 
in the cell cycle [34, 35]. Conversely, loss of activator E2Fs causes cell cycle arrest at 
G1 phase [36]. Accordingly, DP1 is required for G1/S transition and cell prolifera-
tion in human fibroblasts [13]. These observations indicate that the activator E2F/
DP complexes promote and regulate the G1/S transition in cultured cells. However, 
subsequent studies revealed that the cell cycle arrest caused by concomitant loss of 
activator E2Fs in cultured fibroblasts is mediated through the p53-p21 axis, which 
reduces cdk activity [37]. Inactivation of p53 restores the proliferative ability of 
E2f1–3 triple mutant fibroblasts [38]. These results suggest that cells have permis-
sive factor(s), which promote G1/S transition in the absence of activator E2Fs, and 
raise the question of how activator E2Fs suppress p53 activity in proliferating cells. 
A strong candidate of E2F target genes that induce activation of p53 in this context 
was Arf, since permanent loss of E2f3 induces Arf expression [38, 39]. However, 
acute inactivation of E2F activators does not increase Arf expression and activa-
tion of p53 does not require Arf in E2f1–3 triple mutant fibroblasts [38]. Therefore, 
induction of Arf gene expression by loss of E2f3 is presumably an indirect effect 
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and activator E2Fs suppress activation of p53 by Arf-independent mechanisms 
in fibroblasts. Elucidating the mechanisms, by which activator E2Fs suppress p53 
activity in proliferating cells, will provide deeper understanding of how activator 
E2Fs regulate cell proliferation.
Cell culture systems and in vitro biochemical experiments have also revealed 
molecular mechanisms underlying transcriptional regulation of target genes by 
the E2F/DP complex [1, 2, 5]. Expression levels of growth-related E2F target genes 
are very low in quiescent fibroblasts, while serum stimulation increases the expres-
sion of these genes concomitant with phosphorylation of pRb family proteins 
by G1-cyclin/cdks [1–5]. Indeed, loss of all Rb family genes increases the level of 
growth-related E2F target gene expression in quiescent mouse fibroblasts [40]. The 
concept that pRb/E2F/DP complex actively represses the transcription of growth-
related E2F target genes in quiescence was conceived based on results from reporter 
assays, in which the promoter region of an E2F target gene is isolated and fused 
upstream of a reporter gene such as chloramphenicol acetyltransferase or luciferase 
to monitor promoter activity [34, 41]. Analysis of such reporter activity during 
the cell cycle revealed that the wild-type promoter recapitulates endogenous gene 
expression patterns throughout the cell cycle, while mutations in canonical E2F 
binding sites de-represses the promoter activity in quiescence and does not allow 
further up-regulation at the G1/S transition (Figure 3). E2F4 and p130 occupied 
canonical E2F binding sites on promoters of growth-related E2F target genes in 
quiescence [14, 16]. DP1 is required for E2F4 binding on the promoter of cdc6 in 
quiescent human fibroblasts and for repression of the cdc6 promoter activity [13] 
(Komori & Ohtani unpublished data). pRb family proteins repress E2F target 
promoter activity by recruiting histone modifier proteins and chromatin remodel-
ing complexes [42–47]. Thus, the repressor E2F/DP complex acts as a platform on 
the target promoters to recruit pRb family proteins, which induce a dynamic change 
of chromatin structure, robustly shutting down the transcription of growth-related 
E2F target genes (Figure 1B).
Activator E2Fs induce stronger activation of E2F target gene transcription 
compared to repressor E2Fs in reporter assays. Co-overexpression of DPs induces 
further activation of reporter transcription while knockdown of DP1 reduces pro-
moter activity induced by activator E2Fs [13, 48, 49]. Thus, DP is essential for both 
active repression and activation of growth-related E2F target gene transcription 
Figure 3. 
The promoter activity of growth-related E2F target genes during the cell cycle. Solid line indicates the activity 
of wild-type promoter of growth-related E2F target genes. Dashed line indicates the activity of canonical E2F 
binding site mutant promoter of growth-related E2F target genes. The difference in promoter activity between 
wild-type and E2F binding site mutant is due to pRB/E2F/DP complex-dependent repression. Activator E2Fs 
increase the wild-type promoter activity to a higher level than the mutant promoter activity at the G1/S phase 
transition.
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(Figure 1B). The main role of DP in the regulation of growth-related E2F target 
gene expression is in DNA binding of the E2F/DP complex [3, 20]. A monomer of 
E2F or DP is able to bind to DNA in vitro, whereas the heterodimer complex shows 
much stronger DNA binding affinity [48, 49]. Structural analysis of the complex of 
E2F4/DP2 bound to a canonical E2F binding site revealed that the E2F/DP complex 
holds DNA by DBDs of both E2F and DP [50]. Thus, DP protein ensures a stable 
binding of the E2F/DP complex to precisely control expression of growth-related 
E2F target genes during the cell cycle.
3.2 The role of the E2F/DP complex in mouse development
In order to form functional tissues and organs, stem cells and progenitor cells 
continuously proliferate to generate progeny cells, which must exit from the cell 
cycle at the onset of commitment to a differentiated state [51]. Because loss of all 
activator E2Fs or loss of DP1 induces cell cycle arrest of cells in culture [13, 36, 52], 
E2f1–3 triple mutant was expected to show a premature exhaustion of cell prolifera-
tion during development. However, the E2f1–3 triple mutant mouse embryo grows 
to mid-gestation stage without severe defects of cell proliferation [53, 54]. In the 
absence of activator E2Fs, the Myc family transcription factors compensate for their 
function to promote the G1/S transition [54, 55]. n-Myc can functionally substitute 
for activator E2Fs in retinal progenitors, while c-Myc complements activator E2Fs 
in intestinal stem cells. E2f1–3 triple mutant embryos also exhibit an apoptotic 
phenotype in multiple tissues, in which activation of p53 is observed. This suggests 
that activator E2Fs suppress the activation of p53 during development in vivo, in 
addition to cells in culture. E2f1–3 triple knock out analysis revealed another aspect 
of the function of activator E2Fs [55]. The expression of growth-related E2F target 
genes is increased by inactivation of E2f1–3 in differentiated cells while loss of 
E2F1–3 reduces the expression of growth-related E2F target genes in proliferating 
progenitor cells, suggesting that E2F1–3 contribute to repress target gene expression 
in differentiated cells. However, loss of E2F1–3 does not induce differentiated cells 
to re-enter into the cell cycle, implying that, in addition to de-repression of growth-
related E2F target genes, other factors are required to cause re-entry of terminally 
differentiated cells into the cell cycle.
Removing all E2f genes from a single mouse is technically impossible at this 
stage. The DP family has three members and DP1 is highly expressed in many 
tissues. Thus, it is anticipated that loss of DP1 would mimic the phenotype expected 
due to elimination of all E2F/DP complexes in the mouse. DP1 mutant mice die in 
utero due to defects in placenta development, while their somatic cells proliferate 
without severe defects [56, 57]. There is a possibility that other DP family proteins 
complement the function of DP1 in DP1 mutant animals. However, the levels of 
DP2 expression are very low in the wild-type and its expression is not significantly 
changed in DP1 mutant embryos. The expression of DP3 has not been investigated 
in DP1 mutant mice. However, since DP3 inhibits activation of growth-related 
target genes by E2F1 in cultured cells [21, 22], it is not likely that DP3 compensates 
for DP1 function. In conclusion, the E2F/DP complex function is required for 
normal development, but the viability seems to be determined by functions that are 
independent from cell cycle control.
3.3 The role of DP in fly development
Mammalian genomes contain several E2F and DP family members, and their 
functional relationships are very complicated. Because the fly genome contains 
two E2Fs, only one DP and no atypical E2Fs, the combinatorial interactions and 
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possibility of compensation by other family members are more limited [4, 33]. In 
drosophila, loss of de2f1 reduces cell proliferation during development [58]. The 
decline in cell proliferation induced by loss of de2f1 is restored by removing de2f2 
gene function, indicating that dE2f1 and dE2f2 have opposite functions in control of 
cell proliferation [31, 32]. dDP mutant larvae phenocopy the de2f1 and de2f2 double 
mutant with respect to cell proliferation and lethality at the late pupal stage [31, 32]. 
The viability of the dDP mutant fly is rescued by restoring the defects in muscle 
development and/or fat body cell growth [59, 60], implying that the lethality is due 
to non-cell cycle function of dDP. These indicate that the E2F/DP complexes are not 
necessary for cell proliferation during fly development. The possibility that dMyc 
may compensate for the function of the dE2f/dDP complex in cell proliferation has 
yet to be examined.
4. The role of atypical E2Fs in endoreplication
4.1 Atypical E2Fs inhibit cell cycle progression in cultured cell
E2F7 and E2F8 are atypical E2F proteins, which are composed of two DBDs 
lacking a transactivation domain or pRb binding motif (Figure 2) [3, 24–29, 33]. 
They do not interact with DP, and thus atypical E2Fs function independently of DP 
protein. Since overexpression of atypical E2Fs represses the promoter activity of 
growth-related E2F target genes, they are designated repressor E2Fs. They function 
via a pRb-independent mechanism. E2F7 recruits the transcriptional co-repressor 
CtBP to repress the activity of its target promoter in fibroblasts [61]. Details of 
molecular mechanisms of how atypical E2Fs regulate E2F target genes have been 
controversial. DBD1 of E2F7 is similar to the DBD of the E2F family, while DBD2 
of E2F7 is homologous to that of the DP family. Both DBDs are necessary for the 
DNA binding ability of atypical E2Fs. Crystal structure analysis revealed that DBD1 
and DBD2 bind to a typical E2F binding site in a manner similar to the E2F4/DP2 
heterodimeric complex [62]. This suggests the possibility that atypical E2Fs are 
able to function as a monomer (Figure 4A). However, they form a homodimer or 
a heterodimer of E2F7 and E2F8 in cells (Figure 4A) [24–29]. How this dimeric 
complex of atypical E2Fs binds to DNA remains to be addressed. In addition, it is 
reported that E2F7 inhibits the function of E2F1 by direct interaction (Figure 4A) 
[61]. How then does an E2F1/E2F7 heterodimer bind to DNA and how does E2F7 
dominate E2F1 activity on their target promoter? Overexpression of atypical E2Fs 
inhibits proliferation of fibroblasts in culture [24–29]. Expression of atypical E2Fs 
is upregulated in G1/S transition of fibroblasts because their expression is under the 
control of typical E2Fs. These suggest that atypical E2Fs may function as a negative 
feedback loop to antagonize the function of activator E2Fs in S-phase of the cell 
cycle. However, cells can proliferate in the presence of atypical E2Fs. If they are 
dispensable in the control of cell proliferation, what is the role of atypical E2Fs in 
the physiological setting?
4.2 Atypical E2Fs control endoreplication during mouse development
Mouse atypical E2Fs play crucial roles in endoreplication of placental tropho-
blast giant cells (TGCs) and liver hepatocytes [3, 33, 63]. While the archetypal cell 
cycle proceeds to G2 and M phases after completing DNA replication, endoreplica-
tion is a variant cell cycle, which repeats the cycle of G1 and S phase in the absence 
of intervening mitoses (Figure 4B) [64]. Consequently, endoreplication produces 
mononucleated polyploid cells. Since endoreplication does not permit cells to enter 
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into mitosis, precise control of mitotic cyclin/cdk activity is important to determine 
the initiation and termination of endoreplication.
Loss of E2f1–3 genes results in continuous excess rounds of endoreplication in 
TGCs, while double knock out of E2f7 and E2f8 genes induces a defect in endorep-
lication [3, 63]. Thus, the activator E2F/DP complex promotes exit from endorep-
lication, while atypical E2Fs maintain it. The reduced number of endoreplication 
cycles in E2f7 and E2f8 double mutant TGCs is partially restored by eliminating 
the function of E2f1. These results indicate that DP-independent E2F regulation by 
atypical E2Fs competitively antagonizes the function of DP-dependent E2F regula-
tion by typical E2Fs during endoreplication (Figure 4B). Atypical E2Fs suppresses 
the expression of Cyclin A as well as cdc2, preventing the entry into M phase during 
endoreplication. The transient up-regulation of atypical E2F expression during 
S phase is important to suppress the expression of target genes immediately after 
DNA replication [24–29]. However, the transient accumulation of atypical E2Fs 
does not instruct the timing of initiation and termination of endoreplication. 
The basal level of their expression is changed during tissue development [63]. 
An increase in the basal level of atypical E2Fs expression allows cells to initiate 
endoreplication, while a reduction in basal levels of atypical E2Fs induces cells 
to exit from endoreplication. Thus, a combination of developmental and cell 
cycle cues determines the timing and duration of endoreplication during tissue 
development.
4.3 Endoreplication in fly development
Fly is a model organism that lacks atypical E2f genes in its genome [4, 33]. Yet, 
endoreplication is conducted in cells of multiple tissues including secretory cells of 
Figure 4. 
Atypical E2Fs regulate growth-related E2F target genes by DP-independent mechanism(s) and control 
endoreplication. (A) Possible mechanisms to repress target promoters by atypical E2Fs. Atypical E2Fs repress 
the transcription of their target genes by forming a dimer of atypical E2Fs, or monomer, or binding to an 
activator E2F. (B) Archetypal cell cycle and endoreplication. Four phases (G1, S, G2, M) are proceeded in the 
archetypal cell cycle, while endoreplication repeats G1 and S phases. Atypical E2Fs are induced at G1/S phase 
and antagonize activator E2Fs at S phase in an endoreplication cycle. (C) Endoreplication in fly. Cul4 induces 
an acute degradation of dE2f1 to skip G2 and M phases.
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salivary glands, subperineural glia of the brain, and ovarian nurse and follicle cells 
[64]. How is cdk activity downregulated immediately after DNA replication in these 
cell types without atypical E2Fs? Instead of atypical E2F-mediated suppression of 
E2F target gene expression, ubiquitin ligase Cul4 induces a rapid degradation of 
dE2f1 during S phase, reducing the expression of E2F target genes including Cyclin 
E and mitotic cyclins (Figure 4C) [65]. Downregulation of Cyclin E/cdk2 activ-
ity during S phase does not allow cell cycle to progress through the G2/M phase 
transition in fly, thereby returning the cell cycle back into G1 phase, resulting in 
endoreplication [66, 67]. These observations imply that organisms lacking atypical 
E2Fs have mechanism(s) to complement their function.
5. The role of E2F1 in apoptosis and tumor suppression
5.1 E2F1 induces apoptosis in a DP-independent manner in mammalian 
fibroblasts
Cultured cell systems also demonstrated that E2F1 can function to induce apop-
tosis [1, 2, 7]. Overexpression of E2F1 induces p53-dependent and p53-dependent 
apoptosis in cultured cells in the absence of survival signals provided by serum 
(Figure 5A). Overexpression of E2F1 induces the expression of Arf, which activates 
p53 through suppression of MDM2 [1, 2, 5, 10, 68]. E2F1 bypasses p53-dependent 
apoptosis by inducing the expression of the p53 homolog, p73 [69, 70]. In contrast 
to control of cell proliferation, DP1 and DP2 are not necessary for E2F1-induced 
apoptosis [13], indicating that E2F1-induced apoptosis is the second model of 
DP-independent E2F function. The function of E2F1 to induce apoptosis is intui-
tively contradictory to its role in promoting cell proliferation. Why does E2F1 
protein have these opposing roles? Since endogenous pRb family proteins are unable 
to suppress the activity of E2F generated by overproduction of E2F, exogenous 
overexpression of E2F1 is supposed to recapitulate deregulated E2F activity that 
results from functional defects in pRb family proteins. Consistent with this theory, 
adenovirus E1A protein, which directly binds to pRb and inhibits its function, 
also induces apoptosis through the Arf-MDM2-p53 pathway in fibroblasts [71–73]. 
Therefore, the role of E2F1-mediated apoptosis has been interpreted as a defensive 
mechanism to protect against and/or counter oncogenic activation of E2F1 that 
induces abnormal proliferation in the context of pRb dysfunction.
5.2 DP-independent regulation of Arf expression by E2F1 in mammalian 
fibroblast
The transcription of the Arf and p73 genes is not increased by endogenous E2F 
activated by serum stimulation in fibroblasts, while the expression of growth-
related E2F target genes is induced (Figure 5B) [10, 12]. One possible explanation 
of the inability of endogenously activated E2F to increase Arf and p73 expression 
is that serum stimulation activates survival signals that specifically counteract the 
induction of apoptotic genes by E2F [74]. Phosphatidylinositol-3 kinase (PI3K) 
signaling inhibits expression of some apoptotic genes, induced by overexpression of 
E2F1, such as AMPKa2, which is involved in metabolism and is not a typical apop-
totic gene [75]. However, it is not clear whether the PI3K signaling regulates these 
genes at the transcriptional level or post-transcriptional level. In addition, PI3K 
signaling does not suppress the induction of Arf gene expression by overexpression 
of E2F1 [76]. Therefore, mechanisms must exist to allow the Arf gene to specifically 
sense and respond to deregulated E2F activity.
Gene Regulation
10
We have approached this issue by investigating mechanisms of how E2F regu-
lates Arf gene expression in human fibroblast [10, 13]. Analysis of Arf promoter 
regulation has revealed the following points. (i) the pRb/E2F/DP complex does 
not actively suppress the Arf promoter during the cell cycle (Figure 5C). (ii) The 
Arf promoter is very sensitive to deregulated E2F activity, but not to E2F activity 
induced by serum stimulation. (iii) E2F1 regulation of the Arf promoter does not 
require DP. (iv) The regulation is mediated through a non-canonical E2F bind-
ing site, EREA (Figure 5C). The sequence of EREA is highly conserved in the Arf 
promoters in human and mouse and an isolated EREA reporter construct from the 
mouse Arf promoter showed similar activity in response to serum stimulation and 
overexpression of E2F1. Thus, E2F regulation of EREA may be shared between 
mouse and human [10]. Our finding raised a new question of how E2F1 binds to 
EREA. In vitro studies showed that, while E2F1 alone is able to bind to a canonical 
E2F binding site, the presence of DP1 drastically enhances E2F1 binding affinity to 
this DNA element. In contrast, the presence of DP does not impact E2F1 binding to 
EREA. Since the presence of DP does not interfere with E2F1 binding to the EREA, 
the E2F/DP complex perhaps binds to EREA utilizing only the E2F DBD. In general, 
a transcription factor works in combination or acts synergistically with a functional 
partner protein. Thus, there may be specific factor(s) that cooperatively function 
with E2F1 to regulate EREA.
In parallel to our study, Hallstrom et al. reported different mechanisms of 
regulation of E2F1-induced apoptosis [74, 77]. They found that (i) The MB domain 
determines specificity of E2F1 to induce apoptosis. A chimeric E2F1 mutant 
containing E2F3 MB loses the ability to induce apoptosis, while insertion of the 
E2F1 MB domain into E2F3 confers the ability to induce apoptosis. (ii) E2F1 binds 
Figure 5. 
E2F1 regulation of Arf gene transcription and apoptosis in Rb-deficiency. (A) Schematic view of E2F1-induced 
apoptosis. E2F1 induces apoptosis through p53-dependent and -independent mechanisms. (B) Arf promoter activity 
during the cell cycle. Black line indicates the activity of the wild-type promoter of growth-related E2F target genes. 
Dashed black line indicates the activity of canonical E2F binding site mutant promoter in growth-related E2F 
target genes. Red line indicates the activity of the Arf promoter. (C) E2F regulation of the Arf promoter in normal 
cell proliferation and in the context of deregulated E2F activity in response to dysfunction of pRb.
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to Jab1, a subunit of the COP9 signalosome (CSN), through its MB domain. The 
E2F1-Jab1 interaction is specific to E2F1 because the amino acid sequence of MB 
domain varies among individual E2F proteins. (iii) Jab1 enhances E2F1-indued acti-
vation of p53 and apoptosis. (iv) Jab1 enhances induction of Arf gene expression by 
overexpression of E2F1. (v) Jab1 binds to the Arf promoter [78]. These are indirect 
evidence, but suggest that Jab1 contributes to activation of Arf gene transcription 
by E2F1, leading us to postulate that the EREA plays a role in Jab1 binding to the Arf 
promoter. Further investigation will be required to reveal details of mechanisms 
underlying E2F regulation of Arf gene expression and apoptosis.
5.3 Arf suppresses tumorigenesis in the Rb mutant mouse
Homozygous mutation of the Rb gene induces ectopic proliferation and apopto-
sis in multiple tissues of mouse embryos [3, 79]. These phenotypes are rescued by 
removing E2f1 gene function [80], suggesting that pRb regulates E2F activity and 
deregulated E2F1 induces apoptosis in vivo. Ablation of the Arf gene does not sup-
press the apoptotic phenotype in Rb homozygous mutant embryos [81], indicating 
that E2F1 induces apoptosis through Arf-independent mechanisms in particular cell 
types. The Rb gene is one of the most prominent tumor suppressor genes and loss of 
pRb function is observed in wide variety of human cancers [5]. Heterozygous muta-
tion predicts retinoblastoma and osteoblastoma in human [5]. These observations 
suggest that E2F1-induced Arf may counteract tumorigenesis in Rb mutant cells. 
In a mouse model, heterozygous mutation of Rb typically produced pituitary and 
thyroid tumors, which is used in study of tumor suppressive function of Rb in vivo 
[79]. In these tumors, wild-type Rb allele is also lost during tumor formation and 
loss of E2f1 suppresses tumorigenesis in heterozygous Rb mutant mice [82], indicat-
ing that E2F1 is deregulated to induce abnormal proliferation in these tumor cells. 
In addition, because the tumor phenotype in pituitary and thyroid of Rb heterozy-
gous mutant mouse is exacerbated by loss of Arf [81], it is likely that deregulated 
E2F1 activity counteracts tumor formation through inducing Arf in these tumors. 
Rb−/+; Arf−/− compound mutant mice develop pituitary gland lesions earlier than 
Rb−/+ and Rb−/+; p53−/− [81]. Therefore, Arf should function independently of p53 to 
suppress tumor formation in the pituitary and thyroid glands of Rb mutant mice.
5.4 E2F-induced apoptosis in fly requires DP
Overexpression of de2f1 or homozygous mutation of rbf1 induces apoptosis 
in multiple tissues in the fly [4, 83], indicating that consistent with vertebrates, 
deregulation of dE2f1 induces cell death in fly. However, there are two inconsistent 
observations. Firstly, dE2f1 requires dDP to induce apoptosis [4, 84, 85]. Secondly, 
dE2f1-induced apoptosis is primarily independent of p53 [86]. The role of fly p53 in 
apoptosis is not as predominant as that of mammalian p53 and the Arf gene does 
not exist in the fly genome. Mechanisms of both E2F1-induced and p53-dependent 
apoptosis, and interactions between them, may have been modified and adapted 
during the process of evolution.
6. Conclusion and perspective
In this chapter, we considered multiple roles of E2F transcription factor by intro-
ducing three distinct mechanisms of E2F-mediated transcription. The classic model 
of the E2F/DP complex explains how the heterodimeric complex regulates growth-
related E2F target genes by collaborating with pRb family proteins during the cell 
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cycle [1–5]. There is no doubt that the pRb/E2F/DP pathway instructs both entry into 
and exit from the cell cycle. However, recent studies revealed that cells have comple-
mentary mechanisms in control of cell cycle progression at the G1/S phase transition. 
Future studies should address the mechanisms, by which cells can control the exit 
from the cell cycle in the absence of the pRB/E2F/DP complex. The classic E2F/DP 
model is not sufficient to explain all function of E2F family proteins. Two additional 
mechanisms, described above, at least partly fill that knowledge gap. Atypical E2Fs 
play a crucial role in endoreplication by antagonizing the function of activator E2Fs in 
DP-independent and Rb-independent manners [3, 33, 63]. In addition to their role in 
endoreplication, atypical E2Fs may also mediate tumor suppression in multiple tissues 
including liver and skin [87, 88]. How they function in suppressing tumorigenesis is 
an important question for future studies. E2F1 also functions via DP-independent 
mechanisms, which mediate tumor suppression via regulation of apoptotic genes 
including Arf [13]. In addition to modulating tumor suppression, these E2F1 path-
ways may have a role in restricting the plasticity of cell fate in differentiated cells. 
Overexpression of four transcription factors (Oct4, Sox2, c-Myc and klf4) reverts 
the competence of fibroblast to the level of pluripotent embryonic stem cells [89]. 
The efficiency of this reprograming is restricted by the pRb-p53 pathway [90, 91]. 
E2F-dependent transcription of Arf, or regulation of p53, may be involved in the 
mechanism to restrict the plasticity of cell fate in fibroblasts. In addition, Rb and Arf 
contribute to limit the reversion of myocytes to myoblasts in regeneration of muscle 
[92]. These possibilities merit further investigation, and discoveries of new mecha-
nisms of E2F regulation of its target genes will open a new paradigm to understand 
the diverse roles of E2F transcription factor families.
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